| 2019 ( ₹ in Cr. ) | 2018 ( ₹ in Cr. ) | 2017 ( ₹ in Cr. ) | 2016 ( ₹ in Cr. ) | 2015 ( ₹ in Cr. ) | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | 0.59 | 2.3 | 0.31 | 0.2 | 0 |
| Other Income | 0.17 | 0.16 | 0 | 0 | 0 |
| Stock Adjustments | 0 | 0 | 0 | 0 | 0 |
| Total Income | 0.76 | 2.46 | 0.31 | 0.2 | 0 |
| EXPENDITURE : | |||||
| Raw Materials | 0.33 | 0.87 | 0.12 | 0.13 | 0 |
| Excise Duty | 0 | 0 | 0 | 0 | 0 |
| Power and Fuel Cost | 0 | 0 | 0 | 0 | 0 |
| Other Manufacturing Expenses | 0.01 | 1.17 | 0 | 0 | 0 |
| Employee Cost | 0.21 | 0.13 | 0.02 | 0.02 | 0 |
| Selling and Administration Expenses | 0.19 | 0.11 | 0.11 | 0.05 | 0.07 |
| Miscellaneous Expenses | 0.04 | 0.34 | 0.02 | 0.01 | 3 |
| Less: Preoperative Expenditure Capitalised | 0 | 0 | 0 | 0 | 0 |
| Profit before Interest, Depreciation and Tax | -0.01 | -0.16 | 0.03 | -0.01 | -3.07 |
| Interest and Financial Charges | 0 | 0 | 0 | 0 | 0 |
| Profit before Depreciation and Tax | -0.01 | -0.16 | 0.03 | -0.01 | -3.07 |
| Depreciation | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -0.01 | -0.16 | 0.03 | -0.01 | -3.07 |
| Tax | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | -0.01 | -0.16 | 0.03 | -0.01 | -3.07 |
| Adjustment below Net Profit | 0 | 0 | 0 | 0 | 0 |
| P and L Balance brought forward | -5.25 | -5.09 | -5.12 | -5.11 | -2.04 |
| Appropriations | 0 | 0 | 0 | 0 | 0 |
| P and L Bal. carried down | -5.26 | -5.25 | -5.09 | -5.12 | -5.11 |
| Equity Dividend | 0 | 0 | 0 | 0 | 0 |
| Preference Dividend | 0 | 0 | 0 | 0 | 0 |
| Corporate Dividend Tax | 0 | 0 | 0 | 0 | 0 |
| Equity Dividend (%) | 0 | 0 | 0 | 0 | 0 |
| Earning Per Share (Rs.) | 0 | 0 | 0.06 | 0 | 0 |
| Book Value | 0.44 | 0.47 | 0.76 | 0.7 | 0.71 |
| Extraordinary Items | 0.17 | -0.29 | 0 | 0 | -3 |
| 2019 ( ₹ in Cr. ) | 2018 ( ₹ in Cr. ) | 2017 ( ₹ in Cr. ) | 2016 ( ₹ in Cr. ) | 2015 ( ₹ in Cr. ) | |
|---|---|---|---|---|---|
| SOURCES OF FUNDS : | |||||
| Share Capital | 5.47 | 5.47 | 5.47 | 5.47 | 5.47 |
| Reserves and Surplus | -4.89 | -4.88 | -5.05 | -5.08 | -5.08 |
| Total Shareholders Funds | 0.58 | 0.59 | 0.42 | 0.39 | 0.39 |
| Secured Loans | 0 | 0 | 0 | 0 | 0 |
| Unsecured Loans | 0 | 0 | 0 | 0 | 0 |
| Total Debt | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 0.58 | 0.59 | 0.42 | 0.39 | 0.39 |
| APPLICATION OF FUNDS : | |||||
| Gross Block | 0.02 | 0 | 0 | 0 | 0 |
| Less: Accum. Depreciation | 0 | 0 | 0 | 0 | 0 |
| Net Block | 0.02 | 0 | 0 | 0 | 0 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| Current Assets, Loans and Advances | |||||
| Inventories | 0 | 0 | 0 | 0 | 0 |
| Sundry Debtors | 0.29 | 0.34 | 0.02 | 0.02 | 0.02 |
| Cash and Bank Balance | 0.14 | 0.34 | 0.16 | 0.1 | 0.13 |
| Loans and Advances | 0.25 | 0.13 | 0.35 | 0.35 | 0.32 |
| Less: Current Liab. and Prov. | |||||
| Current Liabilities | 0.06 | 0.17 | 0.11 | 0.07 | 0.07 |
| Provisions | 0.06 | 0.06 | 0 | 0 | 0 |
| Net Current Assets | 0.56 | 0.58 | 0.42 | 0.4 | 0.4 |
| Miscellaneous Expenses not w/o | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 0.58 | 0.58 | 0.42 | 0.4 | 0.4 |
| Contingent Liabilities | 0 | 0 | 0 | 0 | 0 |
If I had made LUMPSUM investment of ₹ 1,00,000
in RUBRA MEDICAMENTS LTD.
Months ago
My investment would be worth
₹ 1,41,900
with a Gain of
41.90 %
